238 related articles for article (PubMed ID: 9172070)
1. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy.
Cuda G; Fananapazir L; Epstein ND; Sellers JR
J Muscle Res Cell Motil; 1997 Jun; 18(3):275-83. PubMed ID: 9172070
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
Roopnarine O; Leinwand LA
Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
4. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.
Tyska MJ; Hayes E; Giewat M; Seidman CE; Seidman JG; Warshaw DM
Circ Res; 2000 Apr; 86(7):737-44. PubMed ID: 10764406
[TBL] [Abstract][Full Text] [Related]
5. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
Fananapazir L; Dalakas MC; Cyran F; Cohn G; Epstein ND
Proc Natl Acad Sci U S A; 1993 May; 90(9):3993-7. PubMed ID: 8483915
[TBL] [Abstract][Full Text] [Related]
6. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
Di Domenico M; Casadonte R; Ricci P; Santini M; Frati G; Rizzo A; Carratelli CR; Lamberti M; Parrotta E; Quaresima B; Faniello CM; Costanzo F; Cuda G
J Cell Physiol; 2012 Oct; 227(10):3471-6. PubMed ID: 22213221
[TBL] [Abstract][Full Text] [Related]
7. Isometric tension and mutant myosin heavy chain content in single skeletal myofibers from hypertrophic cardiomyopathy patients.
Malinchik S; Cuda G; Podolsky RJ; Horowits R
J Mol Cell Cardiol; 1997 Feb; 29(2):667-76. PubMed ID: 9140824
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
Cuda G; Fananapazir L; Zhu WS; Sellers JR; Epstein ND
J Clin Invest; 1993 Jun; 91(6):2861-5. PubMed ID: 8514894
[TBL] [Abstract][Full Text] [Related]
9. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
Abchee A; Marian AJ
J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
[TBL] [Abstract][Full Text] [Related]
12. [An analysis of the prevalence of the Arg403Gln, Gly584Arg and Leu908Val mutations in the beta-myosin heavy chain in Portuguese patients who are carriers of familial hypertrophic cardiomyopathy].
Vieira M; Gonçalves L; Ventura M; Vieira M; Providência LA; Pires E; Faro C
Rev Port Cardiol; 1995 Oct; 14(10):733-5. PubMed ID: 7492407
[No Abstract] [Full Text] [Related]
13. Molecular basis of hypertrophic and dilated cardiomyopathy.
Marian AJ; Roberts R
Tex Heart Inst J; 1994; 21(1):6-15. PubMed ID: 8180512
[TBL] [Abstract][Full Text] [Related]
14. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains.
Epstein ND
Adv Exp Med Biol; 1998; 453():105-14; discussion 114-5. PubMed ID: 9889820
[TBL] [Abstract][Full Text] [Related]
15. Myosin mutations in hypertrophic cardiomyopathy and functional implications.
Vosberg HP
Herz; 1994 Apr; 19(2):75-83. PubMed ID: 8194835
[TBL] [Abstract][Full Text] [Related]
16. Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.
Alpert NR; Mohiddin SA; Tripodi D; Jacobson-Hatzell J; Vaughn-Whitley K; Brosseau C; Warshaw DM; Fananapazir L
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1097-102. PubMed ID: 15528230
[TBL] [Abstract][Full Text] [Related]
17. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.
Lankford EB; Epstein ND; Fananapazir L; Sweeney HL
J Clin Invest; 1995 Mar; 95(3):1409-14. PubMed ID: 7883988
[TBL] [Abstract][Full Text] [Related]
18. A Failure to Communicate: MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION.
Kronert WA; Melkani GC; Melkani A; Bernstein SI
J Biol Chem; 2015 Dec; 290(49):29270-80. PubMed ID: 26446785
[TBL] [Abstract][Full Text] [Related]
19. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.
Rayment I; Holden HM; Sellers JR; Fananapazir L; Epstein ND
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3864-8. PubMed ID: 7731997
[TBL] [Abstract][Full Text] [Related]
20. β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity.
Adhikari AS; Trivedi DV; Sarkar SS; Song D; Kooiker KB; Bernstein D; Spudich JA; Ruppel KM
Nat Commun; 2019 Jun; 10(1):2685. PubMed ID: 31213605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
